N/A Completed N=40 Randomized Single-blind Treatment

Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)

Anxiety

Source: ClinicalTrials.gov NCT02579915 ↗

Enrolled (actual)

Serious AEs

2.5%

Results posted

Feb 2020

Primary outcomePrimary: Hamilton Anxiety Rating Scale — 5; 6 Participants

Summary

The purpose of the study is to develop a personalized, user-friendly computerized treatment for anxiety disorders linked to primary care. The computerized treatment is a type of Cognitive Bias Modification, which targets attention and interpretation biases known to maintain anxiety disorders.

Outcome Measures

Outcome	Result	p-value
PRIMARY Hamilton Anxiety Rating Scale	5; 6	—
SECONDARY 7-item Generalized Anxiety Disorder Scale	—	—
SECONDARY Patient Health Questionnaire-9	—	—

Eligibility Criteria

Inclusion Criteria

Study site patient Age ≥18 Primary diagnosis of Generalized anxiety disorder (GAD), Social Phobia (SP), and/or panic disorder with or without agoraphobia (PD/A) At least moderate anxiety severity (GAD-7 score > 10) English-speaking If on psychopharmacotherapy, stable dose for 3 months; to minimize learning effects, patients taking benzodiazepines will complete AIM prior to their first dose of the day No current psychotherapy No current severe psychiatric symptoms requiring immediate attention (e.g., imminent suicidality, psychosis)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02579915). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.